Steris (STE) Tops Q4 EPS by 15c; Offers FY23 Outlook
Get Alerts STE Hot Sheet
Price: $200.40 -1.09%
EPS Growth %: +6.8%
Financial Fact:
Income (loss) before income tax expense (benefit): 15.84M
Today's EPS Names:
OCCI, MAYS, CRMT, More
EPS Growth %: +6.8%
Financial Fact:
Income (loss) before income tax expense (benefit): 15.84M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Steris (NYSE: STE) reported Q4 EPS of $2.30, $0.15 better than the analyst estimate of $2.15. Revenue for the quarter came in at $1.38 billion versus the consensus estimate of $1.27 billion.
GUIDANCE:
Steris sees FY2023 EPS of $8.55-$8.75, versus the consensus of $8.05.
For earnings history and earnings-related data on Steris (STE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- AeroVironment restates quarterly financials, citing $89M goodwill error
- Worried the AI trade has gone too far? Evercore likes these 4 stocks
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share